The World Drug Safety Congress Europe will bring together 1500+ key thought leaders to explore key challenges in pharmacovigilance. From exploring the use of big data and AI in pharmacovigilance, and examining benefit-risk management strategies and patient-centric approaches, drug safety is at the forefront of innovative technologies that will have an impact on the lives of patients.
This meeting will bridge the gap between international regulatory bodies, industry professionals and patient representatives, bringing key actors and across industries and geographical regions.
Nadezda Abramova, Safety Strategy Lead (Merck KGaA) will present the session “Pregnancy and Breastfeeding Regulatory Landscape Assessment: Outcomes and Proposed Solutions” on behalf of TransCelerate’s Interpretation of Pharmacovigilance Guidances & Regulations Initiative.